Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...

The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

In this video, Sham Mailankody, MBBS, discusses results from the long-term follow-up of CARTITUDE-1 patients receiving ciltacabtagene autoleucel, or cilta-cel, for the treatment of relapsed or ...

Multiple myeloma involves a comprehensive approach that combines blood tests, imaging, and bone marrow studies. Learn about ...

Over the past three decades, tremendous achievements have been made in the treatment of patients with multiple myeloma (MM), ...

When you get a diagnosis of multiple myeloma, you may not even know what it is. Find out why this type of cancer is different from most others and what your treatment options look like.

Ideally, treatment for multiple myeloma puts you into remission. If you relapse, your doctor will likely try a different treatment. The period of time between relapses varies from person to person.

We diagnose multiple myeloma by doing blood, urine, bone marrow, and imaging tests. The disease can be classified as being “smoldering myeloma,” which is typically closely monitored, and “active ...

Multiple myeloma is a neoplastic plasma-cell disorder that is characterized by clonal proliferation of malignant plasma cells in the bone marrow microenvironment, monoclonal protein in the blood ...

Nearly all multiple myeloma patients are over age 45. Mr. Powell was 84. But it is rare, accounting for just 1.8 percent of cancers in the United States with 34,920 new cases a year, ...